Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • dhanapala
    Junior Member
    • Nov 2011
    • 8

    Biological Replicate for RNASeq ?

    • What will be the minimum number of biological replicates (plant samples) and how many biological replicates are needed for RNA-Seq using HIseq ?
  • jwfoley
    Senior Member
    • Jun 2009
    • 183

    #2
    Depends on your experimental design, but absolutely not less than two per experimental condition. It doesn't matter which platform you use.

    Comment

    • cascoamarillo
      Senior Member
      • Oct 2010
      • 164

      #3
      One more question about the "replicate" definition; if you have a cDNA from a biological sample (for a RNA-seq experiment) and you use it into two PCR reactions with different barcodes (like the one you do before the Illumina run), the barcode1 and barcode2 samples from the same cDNA can be considered as "replicates".
      Suppose you want statistical power in your data, and you want to test differential gene expression in programs like DESeq (where it wants replicates to check the so called "shot-noise"); in this case, can they be considered good "replicates"?

      Thanks

      Comment

      • SamCurt
        Member
        • May 2010
        • 40

        #4
        Originally posted by cascoamarillo View Post
        One more question about the "replicate" definition; if you have a cDNA from a biological sample (for a RNA-seq experiment) and you use it into two PCR reactions with different barcodes (like the one you do before the Illumina run), the barcode1 and barcode2 samples from the same cDNA can be considered as "replicates".
        Suppose you want statistical power in your data, and you want to test differential gene expression in programs like DESeq (where it wants replicates to check the so called "shot-noise"); in this case, can they be considered good "replicates"?

        Thanks
        These are more like technical replicates to me...

        Comment

        • jwfoley
          Senior Member
          • Jun 2009
          • 183

          #5
          Yes, these replicates are only testing the reproducibility of the sequencing protocol, which is extremely high. Biological reproducibility is what we're interested in. I would just pool the data from technical replicates as a single biological replicate.

          Comment

          • chadn737
            Senior Member
            • Jan 2009
            • 392

            #6
            I would do no less than three independent biological replicates (i.e. RNA isolated from separate biological samples) of each condition. You can get meaningful results from 2 biological reps, but you are really restricting yourself by doing this, particularly on a HiSeq where you can easily multiplex and still get a lot of reads per sample even on a single lane.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            26 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            20 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            131 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            57 views
            0 reactions
            Last Post SEQadmin2  
            Working...